We now know why some people had severe blood clots after COVID shots, PgII

Key Highlights:

• In early 2021, rare blood clots were reported after COVID-19 vaccinations, mainly with AstraZeneca and Johnson & Johnson vaccines.
• These vaccines used a modified adenovirus to deliver DNA into cells, unlike Pfizer and Moderna's mRNA vaccines.
• The condition, vaccine-induced immune thrombocytopenia and thrombosis (VITT), occurred in 3 to 10 per million vaccinated, causing blood clots and low platelet counts.
• Research showed affected patients produced antibodies against platelet factor 4 (PF4), activating platelets and causing clotting.
• A specific mutation in antibody genes, particularly IGLV3-21*02 or *03, was found in nearly all affected patients.
• The adenovirus protein VII was identified as the trigger, mimicking PF4 and causing the immune system to attack the body's own proteins.

Detailed Insights:

• VITT is characterized by unusual blood clots accompanied by low platelet counts, posing a challenge during the initial COVID-19 vaccine rollout.
• mRNA vaccines deliver mRNA directly into the cell body, while adenovirus vaccines use a modified virus to carry DNA into the cell nucleus.
• The immune system's response to the adenovirus protein VII, which resembles PF4, leads to the production of antibodies that mistakenly target PF4.
• The study identified a specific mutation in antibody genes (IGLV3-21*02 or *03) that alters the electrical charge, causing strong binding to PF4 and activating platelets.
• This discovery allows for future vaccines to be engineered more carefully, enhancing the safety of adenoviral vectors in global immunization efforts.
• The research provides a clear molecular explanation for VITT, resolving concerns and paving the way for safer adenoviral vector vaccines.

Scientific/Technical Concepts Involved:

• mRNA (messenger RNA): A temporary working copy of DNA used to create proteins.
• Adenovirus: A type of virus used as a vector to deliver genetic material into cells.
• Platelet Factor 4 (PF4): A human protein that regulates the formation of blood clots.
• Antibodies: Proteins produced by the immune system to neutralize foreign substances.